Submissions for variant NM_000038.6(APC):c.4709A>G (p.Asp1570Gly)

gnomAD frequency: 0.00002  dbSNP: rs373419559

Total submissions: 7

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
GeneDx	RCV000115095	SCV000149004	uncertain significance	not provided	2024-02-13	criteria provided, single submitter	clinical testing	Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 18199528, 29758216)
Labcorp Genetics (formerly Invitae), Labcorp	RCV004562259	SCV000647533	uncertain significance	Familial adenomatous polyposis 1	2025-01-22	criteria provided, single submitter	clinical testing	This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 1570 of the APC protein (p.Asp1570Gly). This variant is present in population databases (rs373419559, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with APC-related conditions. ClinVar contains an entry for this variant (Variation ID: 127297). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics	RCV000575957	SCV000667430	likely benign	Hereditary cancer-predisposing syndrome	2024-11-08	criteria provided, single submitter	clinical testing	This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Color Diagnostics, LLC DBA Color Health	RCV000575957	SCV001344291	uncertain significance	Hereditary cancer-predisposing syndrome	2024-09-30	criteria provided, single submitter	clinical testing	This missense variant replaces Aspartic acid with Glycine at codon 1570 of the APC protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has been identified in 2/250746 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
All of Us Research Program, National Institutes of Health	RCV003997218	SCV004837957	uncertain significance	Classic or attenuated familial adenomatous polyposis	2023-10-27	criteria provided, single submitter	clinical testing	This missense variant replaces Aspartic acid with Glycine at codon 1570 of the APC protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with APC-related disorders in the literature. This variant has been identified in 2/250746 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Baylor Genetics	RCV004562259	SCV005056516	uncertain significance	Familial adenomatous polyposis 1	2023-12-18	criteria provided, single submitter	clinical testing
PreventionGenetics, part of Exact Sciences	RCV003935095	SCV004753729	uncertain significance	APC-related disorder	2023-12-04	no assertion criteria provided	clinical testing	The APC c.4709A>G variant is predicted to result in the amino acid substitution p.Asp1570Gly. To our knowledge, this variant has not been reported in the literature in individuals with APC-related disorders. This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD, and is interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/127297/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.